Redefining Clinical Trials: Sasha Tyndale on Inclusive Research at AbbVie

Outcomes Rocket

Diseases don't discriminate, so it is crucial that medicines are accessible to and effective for as many people as possible.

In this episode, Sasha Tyndale, Director of Diversity and Patient Inclusion at AbbVie, discusses the company’s commitment to inclusive clinical research, highlighting the importance of representing diverse populations affected by diseases. Sasha shares how her team integrates patient perspectives into clinical program design to proactively address potential barriers. She introduces the ADMIRE program, which is focused on engaging underrepresented healthcare professionals in research. Sasha also emphasizes humanizing the healthcare experience by hearing patient stories and addressing challenges. She delves into AbbVie's bold initiatives, including foundational changes to clinical development processes and partnerships with community organizations to increase access to clinical trials and simplify language in study materials. Finally, Sasha challenges listeners to educate themselves and others about clinical research.

Tune in and learn how to become an advocate for inclusive healthcare!

Resources:

Connect with and follow Sasha Tyndale on LinkedIn.

Discover more about AbbVie on their LinkedIn and website.

Sign up for the ADMIRE program here.

If you are considering participating in AbbVie’s clinical research program, click here.